Modeling human diseases in C. elegans

Julian Ceron Madrigal
PREDOCTORAL RESEARCHERS
  • David Ricardo Ahumada Brena
  • Carmen Martinez Fernandez
  • Dmytro Kukthar
  • Jeremy Vicencio Gumarao
Translational Medicine
Genes, Disease and Therapy

Scientific production

2

PAPERS

Impact factor: 10,748

1 PUBLICATION IN FIRST QUARTILE

1 PUBLICATION IN OPEN ACCESS

Selected publications

  • Saura Esteller J, Sanchez Vera I, Nunez Vazquez S, Jabalquinto Carrasco J, Cosialls AM, Mendive Tapia L, Kukhtar D, Martinez Bueno MD, Lavilla R, Ceron J, Artal Sanz M, Pons G, Iglesias Serret D, Gil J. Fluorizoline-induced apoptosis requires prohibitins in nematodes and human cells. Apoptosis. 2021;26(1-2):83-95. doi:10.1007/s10495-020-01651-z. IF:4,68.
  • Vicencio J, Ceron J. A Living Organism in your CRISPR Toolbox: Caenorhabditis elegans Is a Rapid and Efficient Model for Developing CRISPR-Cas Technologies. CRISPR J. 2021;4(1):32-42. doi:10.1089/crispr.2020.0103. IF:6,07.

Research highlights

PROJECTS

5 Competitive projects

1 Non-competitive project

PUBLISHED WORKS

4 theses

Selected projects

  • MCI21008. Development of CRISPR-Cas technologies in C. elegans to investigate human pathogenic mutations and other gene variants, and to create rare disease models. (PID2020-114986RB-I00). MINISTERIO DE CIENCIA E INNOVACIÓN (MICINN). 2021-2024. IP: CERON MADRIGAL,JULIAN.
  • 20PSJ012. Towards the first tumor in the genetic model Caenorhabditis elegans. (IDEAS20078CERÓ). AECC. 2020-2022. IP: CERON MADRIGAL,JULIAN.
  • 20MEC001. Optimización de CRISPR en C. elegans: nuevos reporteros y reemplazo de genes. (PRX19/00425). MINISTERIO DE EDUCACIÓN Y FORMACIÓN PROFESIONAL. 2020-2021. IP: CERON MADRIGAL,JULIAN.
  • 18AGA001. AJUTS PER CONTRACTAR PERSONAL INVESTIGADOR NOVELL (FI-DGR 2018). (2020 FI_B2 00160). 2018-2021. IP: CERON MADRIGAL, JULIAN.
  • 18PSJ004. Genome editing as prognostic and therapeutic tool in human diseases. 2018-2021. IP: CERON MADRIGAL,JULIAN.